Design Therapeutics, Inc. - DSGN
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$362.3M
QoQ value delta ($000)
+$102.7M
(+39.54%)
Implied price effect (QoQ)
+24.57%
Shares
Total shares
38,629,932
QoQ shares delta
+4,143,403
(+12.01%)
Total shares held by funds (by quarter)
Market chart (DSGN)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 61,218 | 6,526,476 | 8.67% |
| Point72 Asset Management, L.P. | 50,389 | 5,372,004 | 0.06% |
| Logos Global Management LP | 23,450 | 2,500,000 | 1.42% |
| BAKER BROS. ADVISORS LP | 20,946 | 2,233,099 | 0.12% |
| BlackRock, Inc. | 19,858 | 2,117,156 | 0.0% |
| VANGUARD GROUP INC | 15,297 | 1,630,910 | 0.0% |
| Vivo Capital, LLC | 15,129 | 1,612,903 | 0.98% |
| Almitas Capital LLC | 14,355 | 1,530,435 | 3.16% |
| RA CAPITAL MANAGEMENT, L.P. | 13,707 | 1,461,381 | 0.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11,066 | 1,179,817 | 0.08% |
| Woodline Partners LP | 8,855 | 944,039 | 0.03% |
| Kynam Capital Management, LP | 7,359 | 784,606 | 0.47% |
| FMR LLC | 7,234 | 771,268 | 0.0% |
| MORGAN STANLEY | 6,587 | 702,306 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 6,375 | 679,590 | 0.0% |
| STATE STREET CORP | 6,074 | 647,636 | 0.0% |
| ACADIAN ASSET MANAGEMENT LLC | 5,742 | 612,768 | 0.01% |
| Frazier Life Sciences Management, L.P. | 4,886 | 521,000 | 0.13% |
| Caption Management, LLC | 4,690 | 500,000 | 0.03% |
| CITADEL ADVISORS LLC | 4,313 | 459,874 | 0.0% |
| D. E. Shaw & Co., Inc. | 4,116 | 438,894 | 0.0% |
| Invesco Ltd. | 2,868 | 305,757 | 0.0% |
| DIMENSIONAL FUND ADVISORS LP | 2,795 | 297,921 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 2,692 | 287,100 | 0.0% |
| NORTHERN TRUST CORP | 2,688 | 286,572 | 0.0% |